Clinical Trial: Phase III Randomized, Double-Masked, Safety and Efficacy Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Vehicle Control for the Treatment of Moderate to Severe Dry Eye

U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT06903611) titled 'Phase III Randomized, Double-Masked, Safety and Efficacy Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Vehicle Control for the Treatment of Moderate to Severe Dry Eye' on March 25.

Brief Summary: Prospective, multicenter, randomized, vehicle-controlled, double-masked, study of CAM-101 topical ophthalmic solution compared to vehicle control followed by crossover to long-term follow-up open-label treatment with CAM-101 for one year.

Study Start Date: July 30, 2025

Study Type: INTERVENTIONAL

Condition: Dry Eye Disease Dry Eye Dry Eyes Chronic Dry Eye Syndromes

Intervention: DRUG: CAM-101

fibrinogen deple...